Recombinant CD248 (Ontuxizumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7850323

The Biotin-conjugated Humanized Chimeric anti-CD248 (Ontuxizumab Biosimilar) antibody (ABIN7850323) specifically detects CD248 (Ontuxizumab Biosimilar) in FACS and ELISA. The antibody is reactive with Human samples.

Quick Overview for Recombinant CD248 (Ontuxizumab Biosimilar) antibody (Biotin) (ABIN7850323)

Target: CD248 (Ontuxizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: Biotin

Application: Flow Cytometry (FACS), ELISA

Grade: Research Grade

Product Details

Purpose: Biotinylated Anti-TEM1(ontuxizumab biosimilar) mAb

Isotype: E356D, IgG1, M358L, S403F, kappa

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.

Expiry Date: 12 months

Target Details

Target: CD248 (Ontuxizumab Biosimilar)

Alternative Name: ontuxizumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CD248, CD164L1
Synonyms Antibody:MORAb-004

UniProt: Q9HCU0